Selected Protocols for the Treatment of Hematologic Malignancies

A Phase I Trial of Vaccination with Lethally Irradiated Lymphoma … the Treatment of Relapsed or Refractory Multiple Myeloma. Irene M.Ghobrial, MD. 617- 632-4198. Multiple … Mast Cell Leukemia (MCL) +/- Hematological Clonal Non- …

More PDF Content

Selected Protocols for the Treatment of Hematologic Malignancies

  • A Pilot Study of Gleevec (Imatanib Mesylate) in Relapsed/Refractory T Cell Non-Hodgkin’s Lymphoma
  • A Phase I Trial of Vaccination with Lethally Irradiated Lymphoma Cells Admixed with GMCSF Secreting K562 Cells for the Treatment of Follicular Lymphoma Phase II study of Bortezomid/Lenalidomide in Relapsed/ Refractory Mantle Cell*
  • A Phase IA/II, Multicenter, Open-Label Study of HCD122 Administered Intravenously Once Weekly for Four Weeks in Patients with Advanced Non-Hodgkin’s or Hodgkin’s Lymphoma who have Progressed after at Least Two Prior Therapies*
  • A Phase I Study of Obatoclax Mesylate (GX15-070MS) in Jennifer Brown, MD, PhD Combination with Fludarabine and Rituximab in Previously Treated 617-632-6692 Patients with B-Cell Chronic Lymphocytic Leukemia (B-CLL)
  • A Phase I Dose Escalation Study of Lenalidomide (Revlimid) in Combination with Fludarabine-Rituximab for Previously Untreated CLL/SLL*
  • Phase II Safety and Efficacy Study of the Monoclonal Antibody CT-011 in Patients with Diffuse Large B-Cell Lymphoma following Autologous Stem Cell Transplantation*
  • An Open-Label Phase I Study of the Safety and Efficacy of GCS-100 alone and in combination with Bortezomib and Dexamethasone in Patients with Relapsed or Relapsed/ Refractory Multiple Myeloma
Download Selected Protocols for the Treatment of Hematologic Malignancies pdf from www.dfbwcc.org, 2 pages, 56.3KB.
Related Books

Leave a Reply